Why the study?
Can detailed phenotypic analysis using LTA and ATP secretion reliably diagnose and subclassify heritable platelet function disorders?
Can detailed phenotypic analysis using LTA and ATP secretion reliably diagnose and subclassify heritable platelet function disorders?
Detailed phenotypic analysis using LTA and ATP secretion with a streamlined panel of agonists is a powerful and reliable tool for diagnosing and subclassifying heritable platelet function disorders.
Answers are grounded in this paper and cite their sources.
Supports LTA/ATP testing in suspected PFDs; leaves open reliable subclassification of heritable disorders without prospective validation.
Light transmission aggregometry (LTA) is used worldwide for the investigation of heritable platelet function disorders (PFDs), but interpretation of results is complicated by the feedback effects of ADP and thromboxane A(2) (TxA(2)) and by the overlap with the response of healthy volunteers. Over 5 years, we have performed lumi-aggregometry on 9 platelet agonists in 111 unrelated research participants with suspected PFDs and in 70 healthy volunteers. Abnormal LTA or ATP secretion test results were identified in 58% of participants. In 84% of these, the patterns of response were consistent with defects in Gi receptor signaling, the TxA(2) pathway, and dense granule secretion. Participants with defects in signaling to Gq-coupled receptor agonists and to collagen were also identified. Targeted genotyping identified 3 participants with function-disrupting mutations in the P2Y(12) ADP and TxA(2) receptors. The results of the present study illustrate that detailed phenotypic analysis using LTA and ATP secretion is a powerful tool for the diagnosis of PFDs. Our data also enable subdivision at the level of platelet-signaling pathways and in some cases to individual receptors. We further demonstrate that most PFDs can be reliably diagnosed using a streamlined panel of key platelet agonists and specified concentrations suitable for testing in most clinical diagnostic laboratories.
No takes yet. Share an insight, caveat, or question.
Dawood et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: